SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/16/21 Remedent, Inc. 10-Q 12/31/20 66:4.2M Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 180K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 19K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 19K 12: R1 Document And Entity Information HTML 50K 13: R2 Consolidated Balance Sheets HTML 110K 14: R3 Consolidated Balance Sheets (Parenthetical) HTML 41K 15: R4 Consolidated Statements of Operations HTML 107K 16: R5 Consolidated Statements of Comprehensive Income HTML 43K (Loss) 17: R6 Consolidated Statements of Cash Flows HTML 75K 18: R7 Description of the Company and Basis of HTML 25K Presentation 19: R8 Summary of Significant Accounting Policies HTML 57K 20: R9 Long-Term Investments HTML 88K 21: R10 Concentration of Risk HTML 23K 22: R11 Accounts Receivable and Allowance for Doubtful HTML 33K Accounts 23: R12 Inventories HTML 41K 24: R13 Prepaid Expenses and Other Assets HTML 38K 25: R14 Property and Equipment HTML 39K 26: R15 Due to Related Parties and Related Party HTML 23K Transactions 27: R16 Accrued Liabilities HTML 53K 28: R17 Equity Compensation Plans HTML 67K 29: R18 Segment Information HTML 25K 30: R19 Leases HTML 70K 31: R20 Financial Instruments HTML 108K 32: R21 Summary of Significant Accounting Policies HTML 70K (Policies) 33: R22 Summary of Significant Accounting Policies HTML 43K (Tables) 34: R23 Long-Term Investments (Tables) HTML 78K 35: R24 Accounts Receivable and Allowance for Doubtful HTML 33K Accounts (Tables) 36: R25 Inventories (Tables) HTML 41K 37: R26 Prepaid Expenses and Other Assets (Tables) HTML 38K 38: R27 Property and Equipment (Tables) HTML 38K 39: R28 Accrued Liabilities (Tables) HTML 53K 40: R29 Equity Compensation Plans (Tables) HTML 65K 41: R30 Leases (Tables) HTML 69K 42: R31 Financial Instruments (Tables) HTML 107K 43: R32 Description of the Company and Basis of HTML 24K Presentation (Details) 44: R33 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 25K Product warranty liability (Details) 45: R34 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 65K Additional information (Details) 46: R35 Long-Term Investments (Details) HTML 43K 47: R36 Long-Term Investments - Summary of represent the HTML 48K summary financial information derived from its financial statements and prepared under US GAAP (Details) 48: R37 LONG-TERM INVESTMENTS - Additional information HTML 251K (Details) 49: R38 Concentration of Risk (Details) HTML 33K 50: R39 Accounts Receivable and Allowance for Doubtful HTML 26K Accounts (Details) 51: R40 Inventories (Details) HTML 32K 52: R41 Prepaid Expenses and Other Assets (Details) HTML 31K 53: R42 Property and Equipment (Details) HTML 31K 54: R43 Due to Related Parties and Related Party HTML 21K Transactions (Details) 55: R44 Accrued Liabilities (Details) HTML 43K 56: R45 EQUITY COMPENSATION PLANS - Equity compensation HTML 27K plans approved and not approved by shareholders (Details) 57: R46 EQUITY COMPENSATION PLANS - Additional information HTML 25K (Details) 58: R47 Segment Information (Details) HTML 20K 59: R48 LEASES - Right-of-use assets and related HTML 27K liabilities (Details) 60: R49 LEASES - Maturities of lease liabilities (Details) HTML 33K 61: R50 LEASES - Additional information (Details) HTML 28K 62: R51 FINANCIAL INSTRUMENTS - Carrying values and fair HTML 63K values (Details) 63: R52 FINANCIAL INSTRUMENTS - Additional information HTML 26K (Details) 65: XML IDEA XML File -- Filing Summary XML 116K 64: EXCEL IDEA Workbook of Financial Reports XLSX 70K 6: EX-101.INS XBRL Instance -- remi-20201231 XML 1.24M 8: EX-101.CAL XBRL Calculations -- remi-20201231_cal XML 150K 9: EX-101.DEF XBRL Definitions -- remi-20201231_def XML 241K 10: EX-101.LAB XBRL Labels -- remi-20201231_lab XML 756K 11: EX-101.PRE XBRL Presentations -- remi-20201231_pre XML 563K 7: EX-101.SCH XBRL Schema -- remi-20201231 XSD 135K 66: ZIP XBRL Zipped Folder -- 0001104659-21-024103-xbrl Zip 105K
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Remedent, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
Date: February 16, 2021 | By: | /s/ Guy De Vreese | |
Name: | Guy De Vreese | ||
Title: | Chief Executive Officer (Principal Executive Officer) |
C:
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/16/21 | None on these Dates | ||
For Period end: | 12/31/20 | |||
List all Filings |